GlcNAcylation plays an essential role in breast cancer metastasis

Cancer Research

Volumn 70, Issue 15, 2010, Pages 6344-6351

  Gu, Yuchao ^a   Mi, Wenyi ^a   Ge, Yuqing ^a   Liu, Haiyan ^a   Fan, Qiong ^a   Han, Cuifang ^a   Yang, Jing ^a   Han, Feng ^a   Lu, Xinzhi ^a   Yu, Wengong ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; N ACETYLGLUCOSAMINE; PROTEIN P120; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL SURFACE; CHEMICAL MODIFICATION; CONTROLLED STUDY; FEMALE; GLCNACYLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLGLUCOSAMINE; ACYLATION; ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GLUCOSAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C;

EID: 77955401818     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-1887     Document Type: Article

References (36)

1. Torres CR, Hart GW. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 1984;259: 3308-17.
2. Zachara NE, Hart GW. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev 2002;102:431-8.
3. >Hart GW, Housley MP, Slawson C. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007; 446:1017-22.
4. Park SY, Ryu J, Lee W. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp Mol Med 2005;37:220-9. (Pubitemid 40992738)
5. Yang X, Ongusaha PP, Miles PD, et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 2008;451: 964-9. (Pubitemid 351301737)
6. Buse MG. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 2006;290: E1-8.
7. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci U S A 2004;101:10804-9. (Pubitemid 38955823)
8. Chou TY, Hart GW, Dang CV. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 1995;270:18961-5.
9. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell 2002;2:103-12.
10. Yang WH, Kim JE, Nam HW, et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 2006;8:1074-83.
11. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992;52:1399-405.
12. Macauley MS, Whitworth GE, Debowski AW, Chin D, Vocadlo DJ. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 2005;280:25313-22. (Pubitemid 40962233)
13. Zhu W, Leber B, Andrews DW. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J 2001;20:5999-6007. (Pubitemid 33049275)
14. Sheth P, Seth A, Atkinson KJ, et al. Acetaldehyde dissociates the PTP1B-E-cadherin-β-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. Biochem J 2007;402: 291-300. (Pubitemid 46383426)
15. Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer. Hum Pathol 1987;18:1268-75. (Pubitemid 18018958)
16. Qin JM, Fu XY, Li SJ, et al. Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol 2003;9:2523-7.
17. Gu Y, Zhang J, Mi W, et al. Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res 2008;10:R1.
18. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117:927-39. (Pubitemid 38798858)
19. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A 1990;87: 4246-50. (Pubitemid 20218018)
20. Hu P, Berkowitz P, Madden VJ, Rubenstein DS. Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J Biol Chem 2006;281:12786-91. (Pubitemid 43855370)
21. Pokutta S, Weis WI. Structure and mechanism of cadherins and catenins in cell-cell contacts. Annu Rev Cell Dev Biol 2007;23: 237-61.
22. O'Donnell N, Zachara NE, Hart GW, Marth JD. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 2004;24: 1680-90. (Pubitemid 38167089)
23. Shafi R, Iyer SP, Ellies LG, et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 2000;97: 5735-9. (Pubitemid 30367467)
24. Dehennaut V, Lefebvre T, Sellier C, et al. O-linked N- acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J Biol Chem 2007;282:12527-36. (Pubitemid 47100627)
25. Haltiwanger RS, Grove K, Philipsberg GA. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-acetamido-2- deoxy-D-glucopyranosylidene)amino-Nphenylcarbamate. J Biol Chem 1998;273:3611-7. (Pubitemid 28109786)
26. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med 2002;347:1593-603.
27. Macaluso M, Paggi MG, Giordano A. Genetic and epigenetic alterations as hallmarks of the intricate road to cancer. Oncogene 2003;22: 6472-8. (Pubitemid 37372326)
28. Chen YT, Stewart DB, Nelson WJ. Coupling assembly of the E-cadherin/β-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells. J Cell Biol 1999;144:687-99.
29. Thoreson MA, Anastasiadis PZ, Daniel JM, et al. Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol 2000;148:189-202.
30. Ireton RC, Davis MA, van Hengel J, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol 2002;159:465-76.
31. Xiao K, Oas RG, Chiasson CM, Kowalczyk AP. Role of p120-catenin in cadherin trafficking. Biochim Biophys Acta 2007;1773:8-16.
32. Slawson C, Pidala J, Potter R. Increased N-acetyl-β-glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta 2001;1537:147-57. (Pubitemid 32885616)
33. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008;13:472-82.
34. McClain DA, Crook ED. Hexosamines and insulin resistance. Diabetes 1996;45:1003-9.
35. Wells L, Vosseller K, Hart GW. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell Mol Life Sci 2003;60:222-8.
36. Kawauchi K, Araki K, Tobiume K, Tanaka N. Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification. Proc Natl Acad Sci U S A 2009;106:3431-6.